About Katedra i Klinika Urologii - Akademia Medyczna w Gdansku
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abbott
2
Foresee Pharmaceuticals Co., Ltd.
1
Immatics Biotechnologies GmbH
1
Clinical Trials at Katedra i Klinika Urologii - Akademia Medyczna w Gdansku
During the past decade, Katedra i Klinika Urologii - Akademia Medyczna w Gdansku conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
2001-05-01
Completed
1,000
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
2001-06-01
Completed
941
IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
2010-12-01
2015-07-01
Completed
339
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma
2014-08-01
2017-01-05
Completed
137
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Katedra i Klinika Urologii - Akademia Medyczna w Gdansku
According to Clinical.Site data, the most researched conditions in "Katedra i Klinika Urologii - Akademia Medyczna w Gdansku" are
"Prostatic Neoplasms" (2 trials), "Metastatic Renal Cell Carcinoma" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Katedra i Klinika Urologii - Akademia Medyczna w Gdansku" in a lesser frequency.
Clinical Trials Intervention Types at Katedra i Klinika Urologii - Akademia Medyczna w Gdansku
Most popular intervention types in "Katedra i Klinika Urologii - Akademia Medyczna w Gdansku" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atrasentan" (2 trials), "Cyclophosphamide" (1 trials), "GM-CSF" (1 trials), "IMA901" (1 trials) and "Leuprolide Mesylate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Katedra i Klinika Urologii - Akademia Medyczna w Gdansku
The vast majority of trials in "Katedra i Klinika Urologii - Akademia Medyczna w Gdansku" are
3 trials for "Male" genders and 1 trials for "All" genders.
Clinical Trials Status at Katedra i Klinika Urologii - Akademia Medyczna w Gdansku
Currently, there are NaN active trials in "Katedra i Klinika Urologii - Akademia Medyczna w Gdansku".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Katedra i Klinika Urologii - Akademia Medyczna w Gdansku,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Katedra i Klinika Urologii - Akademia Medyczna w Gdansku, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".